DNA & Genetics Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer PipelineBy adminSeptember 30, 20250 Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster…
DNA & Genetics Non-Neutralizing Antibody Cocktail Effective Against Multiple Flu StrainsBy adminSeptember 10, 20250 Scientists at the Jackson Laboratory (JAX) have developed an antibody-based therapy against influenza A virus (IAV), which they suggest could…
